Pfizer Inc (PFE) currently trades at $27.47, showing a slight increase of 1.37% from the previous close of $27.10. Despite consistent earnings beats in recent quarters, with Q4 2025 EPS of $0.66 surpassing estimates by 15.17%, the company faces challenges with a year-over-year revenue decline of 1.64% and an EPS growth of -3.46%. The stock's P/E ratio of 20.07 suggests it is fairly valued, but the declining growth metrics warrant caution.